← Leaderboards
William J Sullivan Jr
Indiana University Indianapolis
$13,937,697
Attributed
$19,634,674
Total exposure
19
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,634,674 · 19
By mechanism
R01$8,633,267 · 5
RC4$5,630,177 · 1
R21$5,063,392 · 12
R56$307,838 · 1
Top collaborators
- Ronald C Wek14 shared
- Gustavo A Arrizabalaga2 shared
- Lesly A Temesvari2 shared
- Kami Kim1 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Ronald C Wek$16,092,740
Others in their field
Top investigators on “Toxoplasma Gondii”
- L David Sibley · Washington University$42,221,391
- John C Boothroyd · Stanford University$21,342,994
- Christopher A Hunter · University Of Pennsylvania$20,595,527
- Michael W White · University Of California Riverside$17,265,886
- Vernon Bruce Carruthers · Johns Hopkins University$15,672,870
- Gary E Ward · University Of Vermont & St Agric College$14,197,597
Research focus
Toxoplasma GondiiParasitesToxoplasmaCystAcquired Immunodeficiency SyndromeToxoplasmosisInfectionComplexProteinsInsightTissuesGenesPathogenChronicLifeResponseOpportunistic InfectionsAcuteImmunocompromised HostPharmaceutical PreparationsGene ExpressionCellsModificationMediating
Grant awards (49)
Translation initiation factors driving persistence of Toxoplasma gondii bradyzoites in neurons$556,583
R01 · FY2025 · AI · contact PI
Translation initiation factors driving persistence of Toxoplasma gondii bradyzoites in neurons$573,797
R01 · FY2024 · AI · contact PI
m6A mRNA reader proteins in the AIDS-opportunistic pathogen Toxoplasma gondii$234,524
R21 · FY2024 · AI · contact PI
Translation initiation factors driving persistence of Toxoplasma gondii bradyzoites in neurons$573,797
R01 · FY2023 · AI · contact PI
Regulation of cyst formation in the AIDS opportunistic pathogen Toxoplasma$230,070
R21 · FY2023 · AI · contact PI
m6A mRNA reader proteins in the AIDS-opportunistic pathogen Toxoplasma gondii$195,053
R21 · FY2023 · AI · contact PI
Regulation of cyst formation in the AIDS opportunistic pathogen Toxoplasma$190,810
R21 · FY2022 · AI · contact PI
Eradicating latent toxoplasmosis$229,520
R21 · FY2021 · AI · contact PI
GCN5a and cyst development in the AIDS-opportunistic pathogen Toxoplasma$229,520
R21 · FY2021 · AI · contact PI
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS$393,534
R01 · FY2020 · AI · contact PI
Epitranscriptomics in the AIDS-opportunistic pathogen Toxoplasma gondii$232,760
R21 · FY2020 · AI · contact PI
GCN5a and cyst development in the AIDS-opportunistic pathogen Toxoplasma$190,135
R21 · FY2020 · AI · contact PI
Eradicating latent toxoplasmosis$190,135
R21 · FY2020 · AI · contact PI
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS$393,534
R01 · FY2019 · AI · contact PI
The GCN5b acetylation complex in the AIDS pathogen Toxoplasma$385,800
R01 · FY2019 · AI · contact PI
Epitranscriptomics in the AIDS-opportunistic pathogen Toxoplasma gondii$193,487
R21 · FY2019 · AI · contact PI
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS$390,875
R01 · FY2018 · AI · contact PI
The GCN5b acetylation complex in the AIDS pathogen Toxoplasma$385,800
R01 · FY2018 · AI · contact PI
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS$389,080
R01 · FY2017 · AI · contact PI
The GCN5b acetylation complex in the AIDS pathogen Toxoplasma$385,800
R01 · FY2017 · AI · contact PI
Elucidating new and old roles for autophagy-like proteins in Toxoplasma gondii$195,284
R21 · FY2017 · AI
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS$386,080
R01 · FY2016 · AI · contact PI
The GCN5b acetylation complex in the AIDS pathogen Toxoplasma$385,800
R01 · FY2016 · AI · contact PI
Elucidating new and old roles for autophagy-like proteins in Toxoplasma gondii$232,600
R21 · FY2016 · AI
Translational Control of Encystation in the Entamoebae$188,481
R21 · FY2016 · AI
The GCN5b acetylation complex in the AIDS pathogen Toxoplasma$385,800
R01 · FY2015 · AI · contact PI
Translational Control of Encystation in the Entamoebae$235,008
R21 · FY2015 · AI
Manipulation of host cell acetylome in AIDS opportunistic infection$234,000
R21 · FY2014 · AI · contact PI
Inhibition of phosphatase activity as a novel treatment for chronic toxoplasmosis$229,371
R21 · FY2014 · AI · contact PI
GCN5-mediated transcription in AIDS pathogen Toxoplasma$354,549
R01 · FY2013 · AI · contact PI
Manipulation of host cell acetylome in AIDS opportunistic infection$195,000
R21 · FY2013 · AI · contact PI
Inhibition of phosphatase activity as a novel treatment for chronic toxoplasmosis$183,298
R21 · FY2013 · AI · contact PI
GCN5-mediated transcription in AIDS pathogen Toxoplasma$377,180
R01 · FY2012 · AI · contact PI
GCN5-mediated transcription in AIDS pathogen Toxoplasma$377,180
R01 · FY2011 · AI · contact PI
A Systems Biology Approach to the Model Apicomplexan Toxoplasma gondii$5,630,177
RC4 · FY2010 · AI
GCN5-mediated transcription in AIDS pathogen Toxoplasma$380,990
R01 · FY2010 · AI · contact PI
MYST opportunities for Toxoplasma drug development$230,838
R21 · FY2010 · AI · contact PI
Translational control and latent Toxoplasma infection$190,575
R21 · FY2010 · AI
GCN5-mediated transcription in AIDS pathogen Toxoplasma$307,838
R01 · FY2009 · AI · contact PI
Translational control and latent Toxoplasma infection$231,000
R21 · FY2009 · AI
MYST opportunities for Toxoplasma drug development$189,616
R21 · FY2009 · AI · contact PI
GCN5-mediated transcription in AIDS pathogen Toxoplasma$307,838
R56 · FY2008 · AI · contact PI
APEs as novel drug targets in AIDS opportunistic pathogen Toxoplasma$222,932
R21 · FY2008 · AI · contact PI
GCN5-mediated transcription in AIDS pathogen Toxoplasma$242,593
R01 · FY2007 · GM · contact PI
APEs as novel drug targets in AIDS opportunistic pathogen Toxoplasma$189,375
R21 · FY2007 · AI · contact PI
GCN5-mediated transcription in AIDS pathogen Toxoplasma$249,838
R01 · FY2006 · GM · contact PI
GCN5-mediated transcription in AIDS pathogen Toxoplasma$255,850
R01 · FY2005 · GM
GCN5-mediated transcription in AIDS pathogen Toxoplasma$255,850
R01 · FY2004 · GM
GCN5-mediated transcription in AIDS pathogen Toxoplasma$245,119
R01 · FY2003 · GM